GMO: Don’t overlook risk in emerging markets
Cheap valuations aren't the only factor when deciding to invest
Time to remind clients about taxes
No matter what tax reform Congress enacts, funds will still feel a bite
Are music royalties a new alternative investment?
You can get income for a song, but the length of the stream can be hard to predict.
Activists add tailwinds to closed-end funds
Persistent discounts have often caught the eye of activist investors
A shares live on, despite some hefty upfront sales charges
Most of the funds are top performers in their categories over the past five years.
ESG investors like gains as much as anyone else
Flows into environmental, social and governance funds often follow performance.
Will new smart-beta strategies boost target-date funds’ performance?
Some money managers are adding smart-beta strategies to win a bigger slice of the TDF pie. But will they stimulate advisers' hunger?
Fidelity: Will Goldilocks market have a happy ending?
Analyst at the money manager says high returns and low volatility are not normal.
Dominated by women, tech-heavy fund is up 36% on the year
Seattle-based Zevenbergen Genea observes what products consumers are gravitating to when picking stocks.
Growth funds soar in first six months of 2017
Large-cap technology, consumer discretionary and health-care were the standouts in the first half.